Tuesday, April 27, 2021 9:26:21 AM
The vaccines have given this false impression, and it is the common spoken word.
In my opinion, this is ridiculous.
Case counts are higher today than ever.
A high percentage of people are refusing the vaccines.
The vaccines’ length of efficacy is entirely unknown.
SARS-CoV-2 has mutated with variants, as viruses do, from the start, and is likely a long term, if not permanent, issue.
I initially viewed investing in Relief or NeuroRx as a short term play.
Now, I believe the opposite is true. When COPD is talked about in conjunction with RLF-100 (and ARDS in general), this has become a long term investment with a great amount of future potential.
Patience will be rewarded.
~ Money Making Money ~
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM